Scarica l'app Stockscreener
7.93
0.51%
0.04
Dopo l'orario di chiusura:
7.93
Precedente Chiudi:
$7.89
Aprire:
$7.85
Volume 24 ore:
264.86K
Relative Volume:
0.88
Capitalizzazione di mercato:
$403.63M
Reddito:
$227.18M
Utile/perdita netta:
$24.38M
Rapporto P/E:
16.61
EPS:
0.4774
Flusso di cassa netto:
$53.60M
1 W Prestazione:
-0.63%
1M Prestazione:
-2.22%
6M Prestazione:
+22.38%
1 anno Prestazione:
+154.98%
Intervallo 1D:
$7.6301
$7.94
Intervallo di 1 settimana:
$7.6301
$8.23
Portata 52W:
$3.03
$8.75
Puma Biotechnology Inc Stock (PBYI) Company Profile
Nome
Puma Biotechnology Inc
Settore
Industria
Telefono
(424) 248-6500
Indirizzo
10880 WILSHIRE BLVD., LOS ANGELES, CA
Compare PBYI vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
7.93 | 406.69M | 227.18M | 24.38M | 53.60M | 0.4774 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-09-28 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-25 | Ripresa | BofA/Merrill | Underperform |
| 2019-10-08 | Downgrade | Goldman | Neutral → Sell |
| 2019-05-10 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | Downgrade | Citigroup | Buy → Neutral |
| 2019-01-17 | Iniziato | Leerink Partners | Mkt Perform |
| 2019-01-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2018-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-11-02 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-17 | Iniziato | Goldman | Sell |
| 2018-05-11 | Reiterato | Stifel | Buy |
| 2017-11-10 | Reiterato | Citigroup | Buy |
| 2017-11-10 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | Reiterato | Stifel | Buy |
| 2017-09-11 | Reiterato | Credit Suisse | Outperform |
| 2017-07-10 | Ripresa | Leerink Partners | Outperform |
| 2017-06-06 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Puma Biotechnology Inc Borsa (PBYI) Ultime notizie
Puma Biotechnology Inc (PBYI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Puma Biotechnology Inc (PBYI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Puma Biotechnology Inc (PBYI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Puma Biotechnology Inc (PBYI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ETFs Investing in Puma Biotechnology, Inc. Stocks - TradingView
PBYI|Puma Biotechnology Inc|Price:7.980|Chg%:-0.030 - TradingKey
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results - WBOC TV
Puma Biotechnology schedules conference call on Q2 2026 results - Bitget
Puma Stock Puma Biotechnology Inc Discount Puma Biotechnology Acquisition Outlet Online PUMA Biotechnology Form S - มูลนิธิเพื่อผู้บริโภค มพบ.
Puma Biotechnology’s Douglas M. Hunt sells $69,904 in shares By Investing.com - Investing.com Nigeria
Puma biotechnology CFO Maximo Nougues sells $77,556 in stock By Investing.com - Investing.com South Africa
Form 4 Puma Biotechnology Inc For: 8 July By Investing.com - Investing.com Nigeria
Alan Auerbach, Puma Biotechnology president and CEO, sells $364,051 By Investing.com - Investing.com South Africa
Puma Biotechnology (PBYI) CEO sells 44,058 shares under 10b5-1 plan - Stock Titan
Puma Biotechnology (PBYI) CFO sells 9,386 shares in 10b5-1 trade - Stock Titan
Alan Auerbach, Puma Biotechnology president and CEO, sells $364,051 - Investing.com
Form 144 PUMA BIOTECHNOLOGY For: 6 July By Investing.com - Investing.com Nigeria
[144] PUMA BIOTECHNOLOGY, INC. SEC Filing - Stock Titan
Price to sales forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView
PBYIPuma Biotechnology Inc Latest SEC Filings - Finviz
Puma Biotechnology highlights targeted cancer therapies as investors watch Nasdaq-listed PBYI - Ad-hoc-news.de
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)July 2, 2026 - BioSpace
PBYI News | PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) - ChartMill
Puma Biotechnology awards stock to four new employees - Stock Titan
Puma Biotechnology, Inc.(NasdaqGS:PBYI) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 2500 Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 2000 Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 3000E Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS:PBYI) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to revenue forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView
Enterprise value to EBITDA forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView
PBYI Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 3000 Growth Benchmark - marketscreener.com
Price to sales forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView
Enterprise value to EBIT forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView
Enterprise value to EBITDA forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView
Puma Biotechnology, Inc. Actuals & Estimates (NASDAQ:PBYI) - TradingView
Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates - Kavout | AI
Puma Pharmaceuticals Puma Biotechnology Puma Biotechnology Puma 2019 Revenue Breast Cancer Treatment - consumerthai
Puma Biotechnology Inc (PBYI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Puma Biotechnology Inc (PBYI) Institutional Confidence - TradingKey
PBYI SEC FilingsPuma Biotechnology Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Puma Pharmaceuticals Clinical Trials Puma Biotechnology Mountain Lion Puma Concolor Lounging By Gerry Ellis - consumerthai
Puma Biotechnology Inc (PBYI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Puma Biotechnology Inc (PBYI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Puma Biotechnology Inc (PBYI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Puma Biotechnology StockShareholders back board but reject warrant extension - AD HOC NEWS
Puma Biotechnology shareholders elect directors and vote on key proposals - Investing.com UK
Puma Biotechnology shareholders elect directors and vote on key proposals By Investing.com - Investing.com South Africa
Puma Biotechnology Shareholders Back Governance, Reject Warrant Extension - TipRanks
Puma Biotechnology Inc Azioni (PBYI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Puma Biotechnology Inc Azioni (PBYI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HUNT DOUGLAS M | See Remarks |
Jul 06 '26 |
Sale |
8.26 |
8,460 |
69,905 |
196,841 |
| NOUGUES MAXIMO F | Chief Financial Officer |
Jul 06 '26 |
Sale |
8.26 |
9,386 |
77,557 |
230,637 |
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):